Iomeron (Iomeprol)

Iomeprol works by delivering iodine atoms into the bloodstream. Iodine strongly absorbs X‑ray photons, so when the solution is injected intravenously it temporarily raises the attenuation of X‑rays in vascular and extracellular compartments, creating a contrast difference that highlights anatomical structures on the scan.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging protocol, patient weight, renal function and the area to be examined. No fixed regimen is provided here; the healthcare professional calculates the appropriate volume for each individual case.

The safety of Iomeron during pregnancy and lactation has not been definitively established. It should only be used when the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. Its viscosity and iodine concentration provide strong image enhancement while reducing the incidence of discomfort and adverse reactions relative to some alternatives.

Iomeron should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperatures. Do not freeze or shake the vial before use; inspect for particulate matter or discoloration prior to administration.

Iomeron is administered as an intravenous injection by a qualified healthcare professional. The solution is typically injected through a peripheral or central vein using a power injector or manual bolus, depending on the imaging protocol and equipment used for the procedure.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and profound hypotension or cardiovascular collapse. Immediate medical intervention is required if any of these events occur.

Iomeron should be avoided in patients with a known hypersensitivity to iodinated contrast media, those with uncontrolled severe thyroid disease, and individuals with markedly reduced renal function where the risk of contrast‑induced nephropathy is high. Contraindications must be confirmed by the prescribing clinician.